Pi-Cardia
Yehud, Israel· Est.
Pi-Cardia creates non‑implant catheter solutions to modify heart valve leaflets for safer transcatheter valve procedures.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Pi-Cardia creates non‑implant catheter solutions to modify heart valve leaflets for safer transcatheter valve procedures.
CardiovascularStructural Heart Disease
Technology Platform
Catheter‑based, non‑implant leaflet modification devices that split or score valve leaflets to improve hemodynamics and reduce procedural risks.
Opportunities
Expansion into global structural heart disease markets and partnership with major valve manufacturers for combined therapeutic solutions.
Risk Factors
Regulatory approvals for investigational devices and competition from alternative leaflet‑modification technologies could delay commercialization.
Competitive Landscape
Pi‑Cardia’s non‑implant approach differentiates it from traditional prosthetic valve companies like Edwards, Medtronic, and Boston Scientific, offering a unique niche solution.